Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
4 April 2018
E-001984-18
Question for written answer
to the Commission
Rule 130
Michaela Šojdrová (PPE)

 Subject:  EU action on vaccination in light of the need to build public trust
 Answer(s) 

The issue of vaccination comes under the protection of public health and as such is primarily the responsibility of the Member States. The EU has the authority to play only a supporting, supplementary and coordinating role. The fact that populations are highly mobile, however, means that this is an issue which transcends the national interest, and the Commission should therefore be proactive in exercising its authority.

In view of (i) the forthcoming proposal for a Council recommendation on strengthening cooperation in the fight against vaccine-preventable diseases, (ii) major interpellation for written answer with debate O-000074/2017, (iii) follow-up interpellations, (iv) the petition for freedom of informed vaccination consent (initiated by the European Forum for Vaccine Vigilance), and (v) repeated suggestions from members of the public expressing doubts about the benefits of compulsory vaccination:
1. In the process of drawing up the aforementioned proposal, has the Commission compared the individual Member States’ systems of compulsory vaccination from the point of view of their impact on public trust in compulsory vaccination and on the resulting level of public health protection? In its proposal, how does the Commission intend to deal with the problem of mistrust of vaccination?
2. How does the Commission assess the appeal by a group of EU citizens who call, in the aforementioned petition, for the establishment of an independent supervisory authority for vaccination to whom vaccines’ adverse effects and their severity could be reported? Would it be possible for this work to be carried out by the European Medicines Agency (EMA)?
Original language of question: CS 
Last updated: 16 April 2018Legal notice